Summary
Image-analysis was used to measure nerves immunoreactive to the general neuronal marker protein gene product 9.5 (PGP 9.5-IR) and the neuropeptides calcitonin gene-related peptide and vasoactive intestinal polypeptide in standardised leg skin biopsies of three age-matched groups of young subjects: non-diabetic (n=14), diabetic patients with normal small fibre function (“non-neuropathic”, (n=11) and diabetic patients with abnormal small fibre function (“neuropathic”, n=11). Depletion of nerves and neuropeptides was most marked in the epidermis, where calcitonin gene-related peptide-immunoreactivity was more frequently absent than PGP 9.5-IR in diabetic patients. Epidermal PGP 9.5-IR nerve area and counts were reduced in neuropathic compared with normal subjects (p<0.001), as were epidermal calcitonin gene-related peptide nerve counts (p=0.003). Sweat gland PGP 9.5 and vasoactive intestinal polypeptide, which may be involved in sweat production, showed no diminution in diabetic patients (area: p=0.160, p=0.372 by ANOVA). Two diabetic patients showed elevated sweat gland PGP 9.5-IR and three had increased sweat gland vasoactive intestinal polypeptide; this may represent nerve proliferation. In local sweat tests, acetylcholine-stimulated sweat output was associated with increased immunoreactivity, while the sympathetic skin response showed inverse correlations with immunoreactivity. There were no consistent changes with other commonly-used neurophysiological tests. HbA1 correlated negatively with immunohistochemical measurements. Neuropeptide changes were seen in the absence of macro- and microvascular disease, and epidermal nerve depletion occurred in patients with normal thermal thresholds and cardiac autonomic function. Immunohistochemical measurement of cutaneous nerves in skin biopsies is a practical method for assessing peripheral small fibres in diabetes, and one which could be repeated in longitudinal studies.
Article PDF
Similar content being viewed by others
References
Bertelsmann FW, Heimans JJ, Van Rooy JCGM, Dankmeijer HF, Visser SL, Van der Veen EA (1987) Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion. J Neurol Neurosurg Psych 50: 1337–1341
Ahmed ME, Le Quesne PM (1986) Quantitative sweat test in diabetics with neuropathic foot lesions. J Neurol Neurosurg Psych 49: 1059–1062
Watkins PJ, Edmonds ME (1983) Sympathetic nerve failure in diabetes. Diabetologia 25: 73–77
Lawrence RD (1965) The diabetic life: a concise practical manual, 17th edn. Churchill, London, p 157
Foreman JC (1987) Peptides and neurogenic inflammation. Br Med Bull 43: 386–400
Wallengren J, Ekman R, Sundler F (1987) Occurrence and distribution of neuropeptides in the human skin. Acta Derm Venereol(Stockh) 67: 185–192
Thompson RJ, Doran JF, Jackson P, Dhillon AP, Rode J (1983) PGP 9.5 — a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 278: 224–228
Wilkinson KD, Lee K, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J (1990) The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246: 670–673
Levy DM, Karanth SS, Springall DR, Polak JM (1989) Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study. Diabetologia 32: 427–433
Lindberger M, Schröder HD, Schultzberg M et al. (1989) Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus. J Neurol Sci 93: 289–296
Levy D, Abraham R, Reid G (1989) A comparison of two methods for measuring thermal thresholds in diabetic neuropathy. J Neurol Neurosurg Psych 52: 1072–1077
Ewing DJ, Clarke BF (1986) Autonomic neuropathy: its diagnosis and prognosis. Clin Endocrinol Metab 15: 855–888
Bloom S, Till S, Sönksen P, Smith S (1984) Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non -diabetic subjects. Br Med J 288: 1793–1795
Levy DM, Rowley DA, Abraham RR (1991) Changes in cholinergic sweat gland activation in diabetic neuropathy identified by computerised sweatspot analysis. Diabetologia 34: 807–812
Levy DM, Reid G, Abraham RR, Rowley DA (1991) Assessment of basal and stimulated sweating in diabetes using a directreading computerized sudorometer. Diabetic Med 8 [Suppl]: S78-S81
Shahani BT, Halperin JJ, Boulu P, Cohen J (1984) Sympathetic skin response — a method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J Neurol Neurosurg Psych 47: 536–542
Karanth SS, Springall DR, Lucas S et al. (1989) Changes in nerves and neuropeptides in skin from 100 leprosy patients investigated by immunocytochemistry. J Pathol 157: 15–26
Cowen T, Alafaci C, Crockard HA, Burnstock G (1987) Origin and postnatal development of nerves showing 5-hydroxytryptamine-like immunoreactivity supplying major cerebral arteries of the rat. Neurosci Lett 78: 121–126
Gale JD, Alberts JCJ, Cowen T (1989) A quantitative study of changes in old age of 5-hydroxytryptamine-like immunoreactivity in perivascular nerves of the rabbit. J Auton Nerv Syst 28: 51–60
Terenghi G, Bunker CB, Liu Y-F et al. (1991) Image analysis quantification of peptide-immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosis. J Pathol 164: 245–252
Dalsgaard CJ, Rydh M, Haegerstrand A (1989) Cutaneous innervation in man visualized with protein gene product 9.5 (PGP 9.5) antibodies. Histochemistry 92: 385–389
Behse F, Buchthal F, Carlsen F, Knappeis GG (1975) Unmyelinated fibres and Schwann cells of sural nerve in neuropathy. Brain 98: 493–510
Kanda T, Tsukagoshi H, Oda M, Miyamoto K, Tanabe H (1991) Morphological changes in unmyelinated nerve fibres in the sural nerve with age. Brain 114: 585–599
Gundersen HJG, Bendtsen TF, Korbo L et al. (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379–394
Levy DM, Springall D, Terenghi G, Reynolds G, Abraham RR, Polak JM (1990) Differential changes in a general neuronal marker and neuropeptides in diabetic skin. Diabetologia 33 [Suppl]: A15 (Abstract)
Aberdeen J, Corr L, Milner P, Lincoln J, Burnstock G (1990) Marked increases in calcitonin gene-related peptide-containing nerves in the developing rat following long-term sympathectomy with guanethidine. Neuroscience 35: 175–184
Kennedy WR, Sakuta M, Quick DC (1984) Rodent eccrine sweat glands: a case of multiple efferent innervation. Neuroscience 11: 741–749
Belai A, Lincoln J, Milner P, Crowe R, Loesch A, Burnstock G (1985) Enteric nerves in diabetic rats: increase in vasoactive intestinal polypeptide but not substance P. Gastroenterology 89: 967–976
Belai A, Lincoln J, Milner P, Burnstock G (1988) Progressive changes in adrenergic, serotonergic, and peptidergic nerves in proximal colon of streptozotocin-diabetic rats. Gastroenterology 95: 1234–1241
Crowe R, Burnstock G (1988) An increase of vasoactive intestinal polypeptide-, but not neuropeptide Y-, substance Por catecholamine-containing nerves in the iris of the streptozotocin-induced diabetic rat. Exp Eye Res 47: 751–759
Webster GJM, Petch EWA, Cowen T (1991) Streptozotocin-induced diabetes in rats causes neuronal deficits in tyrosine hydroxylase and 5-hydroxytryptamine specific to mesenteric perivascular sympathetic nerves and without loss of nerve fibers. Exp Neurol 113: 53–62
Berg TJ, Levy DM, Abraham RR, Reid G (1990) Modulation of methacholine-induced sweating by vasoactive intestinal polypeptide (VIP) and substance P (SP) in diabetic neuropathy. Diabetes 39 [Suppl 1]: 154A (Abstract)
Gorio A (1986) Ganglioside enhancement of neuronal differentiation, plasticity and repair. Crit Rev Clin Neurobiol 2: 241–296
De Koning P, Verhaagen J, Sloot W, Jennekens FGI, Gispen WH (1989) Org. 2766 stimulates collateral sprouting in the soleus muscle of the rat following partial denervation. Muscle Nerve 12: 353–359
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levy, D.M., Terenghi, G., Gu, X.H. et al. Immunohistochemical measurements of nerves and neuropeptides in diabetic skin: relationship to tests of neurological function. Diabetologia 35, 889–897 (1992). https://doi.org/10.1007/BF00399938
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00399938